• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research...
Read morefizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved...
Read moreAstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical...
Read moreAlmac Group, the global contract development and manufacturing organisation, is pleased to announce an expansion to its serialisation capabilities to...
Read moreAstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic®...
Read moreBristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo...
Read moreAstraZeneca and its global biologics research and development arm, MedImmune announced an integrated genomics initiative to transform drug discovery and...
Read moreLEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, announces Svend Andersen as incoming EVP, Head...
Read moreWill Represent Sixth U.S. Patent to Be Listed in the Orange Book for RAVICTI Horizon Pharma plc (NASDAQ: HZNP), a...
Read moreTakeda Licenses Global Rights to Outpost for Novel Clinical Stage Compound for the Potential Treatment of Stress Urinary Incontinence Frazier...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.